Search

everythinglearnresearchcommunity

for

Search:↓

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Three new gene mutations cause rickets and hair loss, treatable with high calcium and calcidol, but hair regrowth is rare.

Transcranial electrical stimulation with bisphosphonates helps maintain bone collagen better than bisphosphonates alone.

Spironolactone is an effective and safe treatment for acne in adult women.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The treatment combination is effective and generally safe for lung cancer.

Genetically modified rats help reveal how vitamin D affects bone and skin health.

Ixekizumab has known and some unexpected side effects.

Dermatologists should monitor potassium levels in women taking spironolactone for acne, hair loss, and hirsutism.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Doxazosin may cause breast enlargement and pain in men.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Spironolactone may help reduce hair loss in androgenic alopecia.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Many patients on methotrexate experience significant side effects but still continue the medication.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Testosterone's muscle-building effects do not require its conversion to DHT.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.